JP2013530965A5 - - Google Patents

Download PDF

Info

Publication number
JP2013530965A5
JP2013530965A5 JP2013515634A JP2013515634A JP2013530965A5 JP 2013530965 A5 JP2013530965 A5 JP 2013530965A5 JP 2013515634 A JP2013515634 A JP 2013515634A JP 2013515634 A JP2013515634 A JP 2013515634A JP 2013530965 A5 JP2013530965 A5 JP 2013530965A5
Authority
JP
Japan
Prior art keywords
seq
cancer
plant defensin
nucleic acid
vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013515634A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013530965A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2011/000760 external-priority patent/WO2011160174A1/en
Publication of JP2013530965A publication Critical patent/JP2013530965A/ja
Publication of JP2013530965A5 publication Critical patent/JP2013530965A5/ja
Pending legal-status Critical Current

Links

JP2013515634A 2010-06-24 2011-06-23 増殖性疾患の治療 Pending JP2013530965A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35812610P 2010-06-24 2010-06-24
US61/358,126 2010-06-24
PCT/AU2011/000760 WO2011160174A1 (en) 2010-06-24 2011-06-23 Treatment of proliferative diseases

Publications (2)

Publication Number Publication Date
JP2013530965A JP2013530965A (ja) 2013-08-01
JP2013530965A5 true JP2013530965A5 (enExample) 2013-10-10

Family

ID=45370753

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013515634A Pending JP2013530965A (ja) 2010-06-24 2011-06-23 増殖性疾患の治療

Country Status (12)

Country Link
US (1) US20120172313A1 (enExample)
EP (1) EP2585095A4 (enExample)
JP (1) JP2013530965A (enExample)
KR (1) KR20140003316A (enExample)
CN (1) CN103037888A (enExample)
AU (1) AU2011269726B2 (enExample)
CA (1) CA2803027A1 (enExample)
MX (1) MX2012014711A (enExample)
NZ (1) NZ603442A (enExample)
SG (1) SG186385A1 (enExample)
WO (1) WO2011160174A1 (enExample)
ZA (1) ZA201208389B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012106759A1 (en) 2011-02-07 2012-08-16 Hexima Limited Modified plant defensins useful as anti-pathogenic agents
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
EP2755693A4 (en) * 2011-09-12 2015-05-20 Moderna Therapeutics Inc MANIPULATED NUCLEIC ACIDS AND METHOD OF APPLICATION THEREFOR
US9540423B2 (en) 2011-10-19 2017-01-10 Balmoral Australia Pty Ltd Plant defensins and use in the treatment of proliferative diseases
SG11201708815UA (en) * 2015-05-29 2017-12-28 Hexima Ltd A method of in vivo treatment
CN111751345A (zh) * 2020-07-08 2020-10-09 深圳海关动植物检验检疫技术中心 一种苜蓿黄萎病菌活性检测方法
KR102371762B1 (ko) * 2020-12-29 2022-03-07 중앙대학교 산학협력단 Brca1 매개 nsd2 유비퀴틴화를 통한 세포 분화 및 세포사멸 조절 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60124000T2 (de) * 2000-08-25 2007-06-28 Basf Plant Science Gmbh Neuartige, für na+/h+ antiporter kodierende pflanzliche polynukleotide
US7041877B2 (en) * 2001-02-08 2006-05-09 Hexima, Ltd. Defensin-encoding nucleic acid molecules derived from nicotiana alata, uses therfor and transgenic plants comprising same
US20070207209A1 (en) * 2004-08-27 2007-09-06 Murphy Christopher J Trophic factor combinations for nervous system treatment
UY32035A (es) * 2008-08-05 2010-01-29 Hexima Ltd Sistemas antipatogenos

Similar Documents

Publication Publication Date Title
JP2013530965A5 (enExample)
JP7270253B2 (ja) ナチュラルキラー細胞のエクスビボ拡大及び活性化のための刺激細胞株
WO2013151672A3 (en) Modified polynucleotides for the production of oncology-related proteins and peptides
JP7164598B2 (ja) トランスジェニックマクロファージ、キメラ抗原受容体、及び関連する方法
JP2018510881A5 (enExample)
HRP20190472T1 (hr) Klaudin-6 specifični imunoreceptori i t-stanični epitopi
NZ739448A (en) Transgene genetic tags and methods of use
JP2016128474A5 (enExample)
PH12022550693A1 (en) Multi-specific binding proteins for cancer treatment
AR068767A1 (es) Anticuerpos contra esclerostina, composiciones y metodos de uso de estos anticuerpos para tratar un trastorno patologico mediado por esclerostina
JP2010540453A5 (enExample)
HRP20171653T1 (hr) Vezna sredstva koja služe ciljano protiv b7-h1
TW201129379A (en) Anti-Orai1 antigen binding proteins and uses thereof
TN2012000393A1 (en) Agonist dr5 binding polypeptides
MX2009008270A (es) Polipeptido novedoso que tiene actividad anti-tumoral.
HK1198170A1 (en) Pseudomonas exotoxin a with less immunogenic b cell epitopes
IL201963A (en) Vectors for multi-gene expression, host cell and pharmacy preparation containing and using them
CN104245736A (zh) 抗人死亡受体5胞外区的人源化单克隆抗体
MX2009005293A (es) Novedosos anticuerpos antiproliferacion.
JP2018509890A5 (enExample)
NZ593893A (en) Gene encoding human glucokinase mutant, enzyme encoded by the same, recombinant vectors and hosts, pharmaceutical compositions and uses thereof, methods for treating and preventing diseases
MX362455B (es) Gen de la toxina axmi335 de bacillus thuringiensis y sus metodos de uso.
CN102863537A (zh) 一种肿瘤靶向性肿瘤坏死因子相关凋亡配体变体及其应用
Su et al. Expression and purification of recombinant ATF-mellitin, a new type fusion protein targeting ovarian cancer cells, in P. pastoris
CN110564767A (zh) 一种减毒病毒载体系统及其在制备抗恶性肿瘤的药物中的应用及药物使用方法